Cargando…
The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident
Autores principales: | Parisa, Ghasemiyeh, Soliman, Mohammadi-Samani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343756/ https://www.ncbi.nlm.nih.gov/pubmed/34212899 http://dx.doi.org/10.23750/abm.v92i3.11683 |
Ejemplares similares
-
COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2018) -
Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
por: Firouzabadi, Negar, et al.
Publicado: (2023)